Abstract: The present disclosure provides methods of treating a disease or delivering a therapeutic agent to a mammal comprising administering to the mammal's cisterna magna and/or ventricle an rAAV particle containing a vector comprising a nucleic acid encoding a therapeutic protein inserted between a pair of AAV inverted terminal repeats in a manner such that cells with access to the cerebrospinal fluid (CSF) express the therapeutic agent and in certain embodiments secretes the therapeutic agent into the CSF for distribution to the brain.
Type:
Grant
Filed:
July 20, 2014
Date of Patent:
August 27, 2019
Assignee:
University of Iowa Research Foundation
Inventors:
Beverly L. Davidson, Luis Tecedor, Yong Hong Chen
Abstract: A real-time applicator position monitoring system (RAPS) measures brachytherapy applicator displacement in real-time by computing the relative displacement between two infrared reflective targets, one attached to the applicator and the other to the patient's skin. In an aspect, RAPS can be used with any brachytherapy application. RAPS measures the applicator motion during HDR brachytherapy treatment, as well as during the transfer of the patient from the imaging room (e.g., where the CT and MR scanners are located) to the HDR BT operating/treatment room.
Type:
Grant
Filed:
December 1, 2016
Date of Patent:
August 13, 2019
Assignee:
University of Iowa Research Foundation
Inventors:
Junyi Xia, Yusung Kim, Timothy J. Waldron
Abstract: Provided are systems and methods for analyzing images. An exemplary method can comprise receiving at least one image having one or more annotations indicating a feature. The method can comprise generating training images from the at least one image. Each training image can be based on a respective section of the at least one image. The training images can comprise positive images having the feature and negative images without the feature. The method can comprise generating a feature space based on the positive images and the negative images. The method can further comprise identifying the feature in one or more unclassified images based upon the feature space.
Type:
Grant
Filed:
March 14, 2014
Date of Patent:
July 23, 2019
Assignees:
University of Iowa Research Foundation, The United States of America, as Represented by the Department of Veterans Affairs
Inventors:
Michael D. Abramoff, Mona K. Garvin, Hu Qiao
Abstract: The invention provides compositions and methods to treat a hyperproliferative disorder with ascorbate or a pharmaceutically acceptable salt thereof, and one or more anti-cancer therapies.
Type:
Application
Filed:
June 6, 2017
Publication date:
July 18, 2019
Applicant:
University Of Iowa Research Foundation
Inventors:
Fenghuang ZHAN, Ivana FRECH, Guido TRICOT
Abstract: Provided herein is compositions and methods for reducing one or both of axonal degeneration and neuronal cell death associated with a disease.
Type:
Application
Filed:
February 12, 2018
Publication date:
July 18, 2019
Applicant:
University of Iowa Research Foundation
Inventors:
Steven L. McKnight, Joseph M. Ready, Andrew A. Pieper
Abstract: A system for disrupting a biofilm on a medical device that comprises an implantable medical device; a magnetically-sensitive coating on the surface of the implantable device comprising a polymer and magnetic particles embedded within the polymer; and a coil element capable of generating an alternating magnetic field, wherein the coil element is constructed and arranged to be capable of applying an alternating magnetic field to induce heating of the surface of the implantable device.
Abstract: The invention is directed at a miniature grism system. The miniature grism system is a single compact device that comprises a grism with collimating and focusing optics. In an aspect, the grism includes at least one prism and a grating. In an aspect, the miniature grism system, and more specifically the grism, includes at least one prism which is placed on either side of the grating. The focusing optics and the collimating optics are found on opposite sides of the grism system, sandwiching the prism and grating of the grism. In an aspect, the miniature grism system is configured to be retained within a filter wheel. The miniature grism system is configured to be used with telescopes having a small focal ratio.
Abstract: The present disclosure provides compositions and methods useful for tissue engineering including a composition having chemically modified RNA (cmRNA) encapsulated in or complexed with a non-viral delivery vehicle and a biocompatible, bioresorbable scaffold and methods of using the composition to regenerate, for example, bone tissue.
Type:
Grant
Filed:
December 29, 2015
Date of Patent:
July 2, 2019
Assignee:
University of Iowa Research Foundation
Inventors:
Satheesh Elangovan, Sheetal Reginald R D'mello, Anh-Vu T Do, Liu Hong, Behnoush Khorsand-Sourkohi, Aliasger K Salem, Michael Kormann
Abstract: The present invention provides a pharmaceutical composition comprising Protein Kinase C Zeta (PKC-?) inhibitor and therapeutic methods for preventing or treating a pathological condition or symptom or for inducing proliferation of lung progenitor cells in a mammal by administering the PKC-? inhibitor.
Type:
Grant
Filed:
October 28, 2015
Date of Patent:
June 25, 2019
Assignee:
University of Iowa Research Foundation
Inventors:
Alejandro P. Comellas Freymond, Xiaopeng Li, Joseph Zabner, Luis Guillermo Vargas Buonfiglio
Abstract: Compositions comprising a reverse-temperature sensitive hydrogel comprising a biopolymer such as a polysaccharide and a synthetic polymer, and a compound in an amount that reversibly inhibits respiratory enzyme complex I, and methods of using the composition, are provided.
Type:
Grant
Filed:
February 13, 2018
Date of Patent:
June 11, 2019
Assignee:
University of Iowa Research Foundation
Inventors:
Todd O. McKinley, James A. Martin, Mitchell Coleman, Tae-Hong Lim, Marc Brouillette
Abstract: Disclosed are compositions, kits, and methods for treating cancer in a subject in need thereof. The compositions, kits, and methods may be used to treat a tumor in a subject in situ. The compositions, kits, and methods comprise or utilize cytotoxic particles, immune checkpoint inhibitors, and/or T-cell stimulatory agents.
Type:
Grant
Filed:
May 16, 2016
Date of Patent:
June 11, 2019
Assignee:
University of Iowa Foundation
Inventors:
Aliasger K. Salem, Amani Makkouk, Vijaya B. Joshi, George Weiner
Abstract: The invention provides for delivery, engineering and optimization of systems, methods, and compositions for manipulation of sequences and/or activities of target sequences. Provided are delivery systems and tissues or organ which are targeted as sites for delivery. Also provided are vectors and vector systems some of which encode one or more components of a SIN CRISPR complex, as well as methods for the design and use of such vectors. Also provided are methods of directing SIN CRISPR complex formation in eukaryotic cells to ensure enhanced specificity for target recognition and avoidance of toxicity and to edit or modify a target site in a genomic locus of interest to alter or improve the status of a disease or a condition.
Type:
Application
Filed:
January 30, 2019
Publication date:
May 23, 2019
Applicants:
The Broad Institute, Inc., Massachusetts Institute of Technology, University of Iowa Research Foundation
Abstract: Compositions and methods to prevent, inhibit or treat aveolar or periodontal bone loss, enhance bone regeneration, prevent, inhibit or treat peri-implantitis or periodontitis, e.g., periodontitis or peri-implantitis associated with bone loss, or to prevent, inhibit or treat osteoarthritis are provided.
Type:
Application
Filed:
January 15, 2016
Publication date:
May 16, 2019
Applicant:
University of Iowa Research Foundation
Inventors:
Liu HONG, Brad A. AMENDT, Aliasger K. SALEM, Satheesh ELANGOVAN, Gustavo Avila Ortiz, Thad SHARP
Abstract: In certain embodiments, the present invention provides the use of microRNA (miR)-200a and/or miR-200c to inhibit ossification and bone formation. In certain embodiments, the present invention provides the use of miR-200a inhibitor to stimulate bone regeneration.
Type:
Grant
Filed:
May 1, 2017
Date of Patent:
April 30, 2019
Assignee:
University of Iowa Research Foundation
Inventors:
Liu Hong, Brad Amendt, Thad Sharp, Aliasger Salem
Abstract: The methods and systems provided can automatically determine an Arteriolar-to-Venular diameter Ratio, AVR, in blood vessels, such as retinal blood vessels and other blood vessels in vertebrates. The AVR is an important predictor of increases in the risk for stroke, cerebral atrophy, cognitive decline, and myocardial infarct.
Type:
Application
Filed:
March 26, 2018
Publication date:
February 28, 2019
Applicants:
University of Iowa Research Foundation, The United States of America, as represented by the Secretary of the Department of Veterans Affair
Inventors:
Michael D. Abramoff, Meindert Niemeijer, Xiayu Xu, Milan Sonka, Joseph M. Reinhardt
Abstract: This disclosure relates to extracts from chestnut plants and compositions comprising compounds contained therein. In certain embodiments, the extracts are derived from the leaves of a Castanea plant. In certain embodiments, the disclosure relates to methods of treating or preventing bacterial infections, acne, and other related uses.
Type:
Grant
Filed:
June 24, 2016
Date of Patent:
February 5, 2019
Assignees:
Emory University, University of Iowa Research Foundation
Inventors:
Cassandra L. Quave, James Lyles, Alexander R. Horswill
Abstract: Disclosed herein are methods and compositions useful in targeting a payload to, or editing a target nucleic acid, where a governing gRNA molecule is used to target, optionally inactivate, a Cas9 molecule or a Cas9 molecule/gRNA complex.
Type:
Grant
Filed:
November 29, 2017
Date of Patent:
January 29, 2019
Assignees:
Editas Medicine, Inc., The Broad Institute Inc., Massachusetts Institute of Technology, University of Iowa Research Foundation
Abstract: A includes receiving data input from a plurality of sources wherein the data input comprises weather data and route data for a vehicle, applying the data input within a decision support system implemented by a computing system to determine an evidence-based probability of risk of delay and crash for the vehicle, and communicating the probability of risk of delay and crash or a decision based on the evidence-based probability of risk of delay and crash to the vehicle or a driver of the vehicle.
Abstract: Described herein are methods of producing biosynthetic bacterial cellulose membranes having improved characteristics that are advantageous for use in various biological applications, including medicine.
Type:
Application
Filed:
December 12, 2016
Publication date:
December 13, 2018
Applicant:
The University of Iowa Research Foundation